Matthew Meade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew Meade has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Alan S. Hilibrand
Rothman Orthopaedic Institute at Thomas Jefferson University Hospital
3 shared publications - Alexander Richard Vaccaro
Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, USA
3 shared publications - Barrett Woods
Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, USA
3 shared publications - Jonathan Dalton
Rothman Orthopaedic Institute
3 shared publications - Mitchell K. Ng
Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, USA
3 shared publications - Yulia Lee
Department of Orthopaedic Surgery, Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, USA
3 shared publications
Latest Publications
- 5 August 2026
- Published by Wolters Kluwer Health in Spine
Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF
Study Design.: Retrospective Cohort Study Objective.: The objective of the present investigation is to evaluate the association between perioperative SGLT2i use and short-term postoperative complications and long-term outcomes following ACDF. Summary of Background Data.: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a class of diabetic medications that provide cardiorenal benefits beyond glycemic control. Despite these benefits, SGLT2i use has been associated with a range of adverse effects. However, the literature remains limited regarding the impact of SGLT2i on perioperative recovery and complications in patients undergoing anterior cervical discectomy and fusion (ACDF). Methods.: A retrospective cohort study was conducted using the TriNetX database. Patients undergoing ACDF were identified and stratified by preoperative SGLT2i use. After 1:1 propensity score matching on demographics and comorbidities, 1,585 patients remained per cohort. Outcomes included postoperative events and long-term sequelae. Risk ratios (RR), 95% confidence intervals (CI), and P values were calculated; Kaplan–Meier curves were used to assess long-term event incidence. Results.: The SGLT2i cohort demonstrated lower rates of postoperative emergency department visits (1.3% vs. 2.2%; RR 0.59, 95% CI 0.34–0.99; P =0.047). At 1-year follow-up, patients receiving SGLT2i had lower rates of pseudoarthrosis (4.9% vs. 6.8%; RR 0.73, 95% CI 0.55–0.97; P =0.028). Reoperation rates at 5 years were also lower in the SGLT2i cohort (2.2% vs. 3.5%; RR 0.64, 95% CI 0.42–0.97; P =0.033). No significant differences were observed in ICU admission, surgical site infection, urinary tract infection, acute kidney injury, or readmission. Conclusion.: Preoperative SGLT2 inhibitor use was associated with reduced postoperative emergency department utilization and lower rates of early pseudarthrosis following ACDF, without an increased risk of short-term complications. Recognition of these risks should inform preoperative counselling, postoperative surveillance, and multidisciplinary care planning for patients undergoing ACDF.
- 5 August 2026
- Published by Wolters Kluwer Health in Spine
Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF
Study Design.: Retrospective Cohort Study Objective.: The objective of the present investigation is to evaluate the association between perioperative SGLT2i use and short-term postoperative complications and long-term outcomes following ACDF. Summary of Background Data.: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a class of diabetic medications that provide cardiorenal benefits beyond glycemic control. Despite these benefits, SGLT2i use has been associated with a range of adverse effects. However, the literature remains limited regarding the impact of SGLT2i on perioperative recovery and complications in patients undergoing anterior cervical discectomy and fusion (ACDF). Methods.: A retrospective cohort study was conducted using the TriNetX database. Patients undergoing ACDF were identified and stratified by preoperative SGLT2i use. After 1:1 propensity score matching on demographics and comorbidities, 1,585 patients remained per cohort. Outcomes included postoperative events and long-term sequelae. Risk ratios (RR), 95% confidence intervals (CI), and P values were calculated; Kaplan–Meier curves were used to assess long-term event incidence. Results.: The SGLT2i cohort demonstrated lower rates of postoperative emergency department visits (1.3% vs. 2.2%; RR 0.59, 95% CI 0.34–0.99; P =0.047). At 1-year follow-up, patients receiving SGLT2i had lower rates of pseudoarthrosis (4.9% vs. 6.8%; RR 0.73, 95% CI 0.55–0.97; P =0.028). Reoperation rates at 5 years were also lower in the SGLT2i cohort (2.2% vs. 3.5%; RR 0.64, 95% CI 0.42–0.97; P =0.033). No significant differences were observed in ICU admission, surgical site infection, urinary tract infection, acute kidney injury, or readmission. Conclusion.: Preoperative SGLT2 inhibitor use was associated with reduced postoperative emergency department utilization and lower rates of early pseudarthrosis following ACDF, without an increased risk of short-term complications. Recognition of these risks should inform preoperative counselling, postoperative surveillance, and multidisciplinary care planning for patients undergoing ACDF.
- Open Access
- 28 July 2026
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 10 (8)
Increasing Utilization of Advanced Practice Providers in Spine Surgery from 2013 to 2022: A Medicare Part B Analysis
Introduction: In modern healthcare systems, the role of advanced practice providers (APPs), including nurse practitioners (NP) and physician assistants (PA), has increased in many settings, in step with the increased demand for healthcare services. The purpose of the present investigation was to evaluate trends in the prevalence, reimbursement, and characteristics of care provided by APPs in the treatment of spinal disorders in the United States from 2013 to 2022. Methods: A retrospective cohort study using the publicly available Medicare Provider Utilization and Payment database from the Centers for Medicare and Medicare Services was conducted on diagnostic, procedural, and therapeutic services provided by advanced practice providers from 2013 to 2022. Provider-type and billing codes were used to identify healthcare professionals providing care for spine patients, such as ordering radiographs, assisting in surgical procedures, or performing office visits. Trends were analyzed using linear regression modeling with projections generated through 2030. Results: Over the study period, the number of surgeons involved in spine care decreased from 3953 (71.2%) in 2013 to 3951 (66.7%) in 2022. The number of APPs who billed for the care of spine patients increased 23.3% from 1600 in 2013 to 1974 in 2022. The most common services billed for by APPs included radiographs and office visits. There were increased odds (OR: 1.20, 95% CI, 1.03-1.41, P < 0.001) of a spine provider in rural areas being an APP versus spine surgeon. Forecasting analysis for 2030 demonstrated continuation of these trends regarding the number of providers, services, and geographic distribution. Discussion: Increased utilization of APPs in the care of patients with spinal pathology is likely to continue with the growing prevalence of patients with spinal disorders.
- 28 July 2026
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 10 (8)
Open AccessIncreasing Utilization of Advanced Practice Providers in Spine Surgery from 2013 to 2022: A Medicare Part B Analysis
Introduction: In modern healthcare systems, the role of advanced practice providers (APPs), including nurse practitioners (NP) and physician assistants (PA), has increased in many settings, in step with the increased demand for healthcare services. The purpose of the present investigation was to evaluate trends in the prevalence, reimbursement, and characteristics of care provided by APPs in the treatment of spinal disorders in the United States from 2013 to 2022. Methods: A retrospective cohort study using the publicly available Medicare Provider Utilization and Payment database from the Centers for Medicare and Medicare Services was conducted on diagnostic, procedural, and therapeutic services provided by advanced practice providers from 2013 to 2022. Provider-type and billing codes were used to identify healthcare professionals providing care for spine patients, such as ordering radiographs, assisting in surgical procedures, or performing office visits. Trends were analyzed using linear regression modeling with projections generated through 2030. Results: Over the study period, the number of surgeons involved in spine care decreased from 3953 (71.2%) in 2013 to 3951 (66.7%) in 2022. The number of APPs who billed for the care of spine patients increased 23.3% from 1600 in 2013 to 1974 in 2022. The most common services billed for by APPs included radiographs and office visits. There were increased odds (OR: 1.20, 95% CI, 1.03-1.41, P < 0.001) of a spine provider in rural areas being an APP versus spine surgeon. Forecasting analysis for 2030 demonstrated continuation of these trends regarding the number of providers, services, and geographic distribution. Discussion: Increased utilization of APPs in the care of patients with spinal pathology is likely to continue with the growing prevalence of patients with spinal disorders.
- Open Access
- 14 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-9
Well-controlled asthma does not adversely affect outcomes following anterior cervical discectomy and fusion
Study Design: Retrospective Cohort Study. Objective: Recent studies have explored the negative impact that respiratory conditions have on outcomes after anterior discectomy and fusion (ACDF). However, the impact that asthmatic status has on postoperative outcomes remains unclear. The purpose of this study was to compare postoperative outcomes between patients with and without asthma who undergo ACDF. Methods: Patients who underwent a primary, elective 1–4 level ACDF (2014–2020) with complete preoperative and 1-year postoperative Neck Disability Index (NDI) surveys were identified. Asthmatic status was determined and stratified into severity. Demographic, comorbidity, perioperative, and PROM data were collected. PROMs included the Visual Analog Scale (VAS) Neck and Arm, Mental Component Summary (MCS), Physical Component Summary (PCS), Modified Japanese Orthopaedic Association (mJOA) score, and NDI. Each PROM was assessed preoperatively and postoperatively at 12 months, with P < 0.05 considered significant. Results: 1195 patients were included (81 (6.78%) had a history of asthma and 1114 (93.2%) did not). Of the asthmatic patients, 37 (45.8%) had well-controlled asthma and 44 (54.3%) had controlled asthma. Asthmatic patients were younger (52.7 vs. 56.1, P = 0.008) and had higher CCI scores (1.04 vs. 0.52, P < 0.001). There were no other differences in demographic variables, ED or readmission rates, 1-year reoperation rates, or PROMs between groups. Conclusion: Patients with well-controlled asthma performed equally as well after anterior cervical fusion as those without asthma. Both groups had similar clinical and patient-reported outcomes, suggesting that having a preoperative diagnosis of well-controlled asthma does not increase risk of postoperative complications after ACDF. Level of Evidence: III.
- 14 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-9
Open AccessWell-controlled asthma does not adversely affect outcomes following anterior cervical discectomy and fusion
Study Design: Retrospective Cohort Study. Objective: Recent studies have explored the negative impact that respiratory conditions have on outcomes after anterior discectomy and fusion (ACDF). However, the impact that asthmatic status has on postoperative outcomes remains unclear. The purpose of this study was to compare postoperative outcomes between patients with and without asthma who undergo ACDF. Methods: Patients who underwent a primary, elective 1–4 level ACDF (2014–2020) with complete preoperative and 1-year postoperative Neck Disability Index (NDI) surveys were identified. Asthmatic status was determined and stratified into severity. Demographic, comorbidity, perioperative, and PROM data were collected. PROMs included the Visual Analog Scale (VAS) Neck and Arm, Mental Component Summary (MCS), Physical Component Summary (PCS), Modified Japanese Orthopaedic Association (mJOA) score, and NDI. Each PROM was assessed preoperatively and postoperatively at 12 months, with P < 0.05 considered significant. Results: 1195 patients were included (81 (6.78%) had a history of asthma and 1114 (93.2%) did not). Of the asthmatic patients, 37 (45.8%) had well-controlled asthma and 44 (54.3%) had controlled asthma. Asthmatic patients were younger (52.7 vs. 56.1, P = 0.008) and had higher CCI scores (1.04 vs. 0.52, P < 0.001). There were no other differences in demographic variables, ED or readmission rates, 1-year reoperation rates, or PROMs between groups. Conclusion: Patients with well-controlled asthma performed equally as well after anterior cervical fusion as those without asthma. Both groups had similar clinical and patient-reported outcomes, suggesting that having a preoperative diagnosis of well-controlled asthma does not increase risk of postoperative complications after ACDF. Level of Evidence: III.
- 2 March 2026
- Published by Wolters Kluwer Health in Clinical Spine Surgery
The Impact of Central and Foraminal Stenosis Severity on the Need for Surgery After Epidural Steroid Injection
Study Design: Retrospective Cohort Study. Objective: This study aimed to identify radiographic and patient-dependent factors that predict failure of epidural steroid injection (ESI) management, leading to subsequent surgical management in patients with lumbar stenosis. Summary of Background Data: Lumbar stenosis is a common cause of radiculopathy and neurogenic claudication, and ESIs are a mainstay of conservative care. However, the benefits of ESIs are debated, and limited evidence exists on how stenosis characteristics correlate with the need for eventual surgery post-ESI. Methods: Adult patients (N=581) who received ESIs for lumbar radiculopathy or spinal stenosis between 2018 and 2021 were retrospectively identified. Subsequent lumbar spine surgery within two years of the first ESI was the primary outcome. Central and foraminal stenosis were graded using preoperative MRIs according to the Guen and Lee classification systems, respectively. Pre- and post-injection pain scores were collected. Multivariate logistic regression was used to determine significant independent predictors of subsequent surgery, accounting for age, body mass index (BMI), diabetes, Charlson Comorbidity Index (CCI), total number of ESIs, central stenosis, and foraminal stenosis. Results: Significant predictors of needing surgery within two years of the first ESI were age (OR 0.96; P P =0.046), diabetes (OR 2.55, 95% CI [1.31, 4.96], P =0.010), total number of ESIs received (OR 1.83, 95% CI [1.46, 2.29], P P <0.001). Central stenosis severity was not a significant predictor of surgery following ESI. Conclusions: In patients treated with initial ESI, foraminal stenosis severity predicted the need for subsequent lumbar spine surgery. Additionally, age, BMI, diabetes, and cumulative number of ESIs were identified as independent predictors of surgery. These findings may assist physicians in counseling patients about the progression of their lumbar stenosis and in predicting the need for future surgery. Level of Evidence: III
- 2 March 2026
- Published by Wolters Kluwer Health in Clinical Spine Surgery
The Impact of Central and Foraminal Stenosis Severity on the Need for Surgery After Epidural Steroid Injection
Study Design: Retrospective Cohort Study. Objective: This study aimed to identify radiographic and patient-dependent factors that predict failure of epidural steroid injection (ESI) management, leading to subsequent surgical management in patients with lumbar stenosis. Summary of Background Data: Lumbar stenosis is a common cause of radiculopathy and neurogenic claudication, and ESIs are a mainstay of conservative care. However, the benefits of ESIs are debated, and limited evidence exists on how stenosis characteristics correlate with the need for eventual surgery post-ESI. Methods: Adult patients (N=581) who received ESIs for lumbar radiculopathy or spinal stenosis between 2018 and 2021 were retrospectively identified. Subsequent lumbar spine surgery within two years of the first ESI was the primary outcome. Central and foraminal stenosis were graded using preoperative MRIs according to the Guen and Lee classification systems, respectively. Pre- and post-injection pain scores were collected. Multivariate logistic regression was used to determine significant independent predictors of subsequent surgery, accounting for age, body mass index (BMI), diabetes, Charlson Comorbidity Index (CCI), total number of ESIs, central stenosis, and foraminal stenosis. Results: Significant predictors of needing surgery within two years of the first ESI were age (OR 0.96; P P =0.046), diabetes (OR 2.55, 95% CI [1.31, 4.96], P =0.010), total number of ESIs received (OR 1.83, 95% CI [1.46, 2.29], P P <0.001). Central stenosis severity was not a significant predictor of surgery following ESI. Conclusions: In patients treated with initial ESI, foraminal stenosis severity predicted the need for subsequent lumbar spine surgery. Additionally, age, BMI, diabetes, and cumulative number of ESIs were identified as independent predictors of surgery. These findings may assist physicians in counseling patients about the progression of their lumbar stenosis and in predicting the need for future surgery. Level of Evidence: III